Beacon Pointe Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Beacon Pointe Wealth Advisors's BMY Position: Q4 2019 in Review
Beacon Pointe Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 7% in Q4 2019, buying an estimated $37.9K and bringing the position to 10,129 shares worth $649K. The position accounts for 0.12% of the portfolio, ranked #139.
Beacon Pointe Wealth Advisors first reported a position in BMY in Q4 2018 and has held it in 5 quarters since. 2,217 funds tracked by Wall St. Rank hold BMY as of Q4 2019.
- Beacon Pointe Wealth Advisors held 10,129 shares of Bristol-Myers Squibb worth $649K as of Q4 2019.
- Beacon Pointe Wealth Advisors bought 661 Bristol-Myers Squibb shares in Q4 2019, an estimated $37.9K.
- Bristol-Myers Squibb made up 0.12% of Beacon Pointe Wealth Advisors's portfolio in Q4 2019, its #139 holding.
- Beacon Pointe Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 5 quarters since.
- 2,217 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.
Based on Beacon Pointe Wealth Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.